Mariner
RPRX icon

Mariner’s Royalty Pharma RPRX Stock Holding History

Mariner’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9M Buy
693,495
+562,839
+431% +$29.3M 0.04% 326
2026
Q1 		$6.27M Buy
130,656
+123,617
+1,756% +$5.41M 0.01% 967
2025
Q4 		$271K Sell
7,039
-20,222
-74% -$771K ﹤0.01% 2932
2025
Q3 		$962K Sell
27,261
-30,742
-53% -$1.11M ﹤0.01% 1939
2025
Q2 		$2.09M Buy
58,003
+10,884
+23% +$361K ﹤0.01% 1311
2025
Q1 		$1.47M Buy
47,119
+21,275
+82% +$674K ﹤0.01% 1416
2024
Q4 		$659K Sell
25,844
-4,772
-16% -$127K ﹤0.01% 1961
2024
Q3 		$866K Sell
30,616
-2,563
-8% -$71K ﹤0.01% 1724
2024
Q2 		$875K Sell
33,179
-3,770
-10% -$105K ﹤0.01% 1605
2024
Q1 		$1.12M Buy
36,949
+6,750
+22% +$199K ﹤0.01% 1428
2023
Q4 		$848K Buy
30,199
+17,491
+138% +$481K ﹤0.01% 1548
2023
Q3 		$345K Sell
12,708
-1,108
-8% -$32.9K ﹤0.01% 2031
2023
Q2 		$425K Sell
13,816
-2,882
-17% -$97.6K ﹤0.01% 1861
2023
Q1 		$602K Buy
16,698
+5,476
+49% +$203K ﹤0.01% 1587
2022
Q4 		$444K Sell
11,222
-974
-8% -$40.7K ﹤0.01% 1736
2022
Q3 		$490K Buy
+12,196
New +$521K ﹤0.01% 1438

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mariner's RPRX Position: Q2 2026 in Review

Mariner increased its Royalty Pharma (RPRX) stake by 431% in Q2 2026, buying an estimated $29.3M and bringing the position to 693,495 shares worth $38.9M. The position accounts for 0.04% of the portfolio, ranked #326.

Mariner first reported a position in RPRX in Q3 2022 and has held it in 16 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Mariner held 693,495 shares of Royalty Pharma worth $38.9M as of Q2 2026.
  • Mariner bought 562,839 Royalty Pharma shares in Q2 2026, an estimated $29.3M.
  • Royalty Pharma made up 0.04% of Mariner's portfolio in Q2 2026, its #326 holding.
  • Mariner first reported a position in Royalty Pharma in Q3 2022 and has held it in 16 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.